Providing market intelligence for more than 35 years

In The News

The Apple Watch Has Gotten Simpler, But That’s OK

Apple’s decision to simplify the watch speaks to a larger issue facing makers of wearables: Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.

“I don’t think Apple wants to be a health-monitoring device maker,” said Harry Wang, director of health and mobile product research at Parks Associates. “They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.”

That information is being gathered through Apple’s new Health app, a dashboard of users’ health data, and HealthKit, a developer tool that lets wellness apps share data. The watch could be populated with messages from external devices and services that track specialized health information.

From the article "The Apple Watch Has Gotten Simpler, But That’s OK" by Stephanie M. Lee.

Previously In The News

Smart Home Gadgets Need To Live Together

Smart home technology that has long been knocking at doors will settle into the mainstream after rival gadgets and services become hassle-free guests that get along with one another, industry insiders...

Extra Miles For Fitness Trackers

Marketing for RecycleHealth got an unexpected boost from an applicant to the digital health communication certificate program, who volunteered her design skills and did a photo shoot of donated device...

Google's Nest Struggles Could Set Back The IoT Movement

The smart home devices sold by Google's home automation subsidiary, Nest, represent just a small fraction of the burgeoning Internet of Things (IoT) market. However, Nest has become one of the most re...

TTA’s Week: Digital Health Funding, Execs’ Wish List, ActivePreventive Responds…And Theranos

We compare two major analyses of 2016 digital health funding, note a tender opportunity and an award in UK, and two more chapters of the Theranos Story. The ActiveProtective CEO responds to Reader and...